ENOCHIAN BIOSCIENCES INC

$2.77 0.00% ($0.00)

Get ready to invest

About ENOCHIAN BIOSCIENCES INC

Enochian BioSciences Inc. is a pre-clinical stage biotechnology company. The Company uses its cell, gene and immune therapy technologies for the treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, as well as to provide cancer remission in some of the deadliest cancers. The Company’s product candidates include ENOB-HV-01, an autologous transplant with genetically modified cells; ENOB-HV-11 and ENOB-HV-12, preventive and therapeutic vaccines; ENOB-HV-21, immunotherapy with allogeneic NK/GDT cells; ENOB-HV-31, in Vivo gene therapy; ENOB-HB-01, potential cure for HBV; ENOB-CV-01, Aerosol/Inhaled treatment potentially for all Coronaviruses that cause human disease; ENOB-CV-11, Aerosol/Inhaled prophylaxis potentially for all coronaviruses that cause human disease; ENOB-FL-01 Aerosol/Inhaled treatment potentially for all influenza viruses; and ENOB-FL-11, Aerosol/Inhaled prophylaxis potentially for all influenza viruses.

Popular Stocks	Price	Change
AMC AMC	$23.73 2.91%	2.91%
AMD AMD	$100.365 0.46%	0.46%
Nvidia NVDA	$187.9869 0.48%	0.48%
Invitae NVTA	$4.7342 11.84%	11.84%
Snap SNAP	$12.1999 4.99%	4.99%
Bed Bath & Beyond BBBY	$15.7239 21.42%	21.42%
Ford F	$16.305 0.77%	0.77%
Apple AAPL	$172.93 0.48%	0.48%
Tilray TLRY	$4.32 7.2%	7.2%
Ironsource Ltd IS	$4.57 13.97%	13.97%